AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Colonno, RJ Genovesi, EV Medina, I Lamb, L Durham, SK Huang, ML Corey, L Littlejohn, M Locarnini, S Tennant, BC Rose, B Clark, JM
Citation: Rj. Colonno et al., Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection, J INFEC DIS, 184(10), 2001, pp. 1236-1245

Authors: Genovesi, EV Lamb, L Medina, I Taylor, D Seifer, M Innaimo, S Colonno, RJ Clark, JM
Citation: Ev. Genovesi et al., Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitisB virus (HBV) infection, ANTIVIR RES, 48(3), 2000, pp. 197-203

Authors: Gong, YF Robinson, BS Rose, RE Deminie, C Spicer, TP Stock, D Colonno, RJ Lin, PF
Citation: Yf. Gong et al., In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632, ANTIM AG CH, 44(9), 2000, pp. 2319-2326

Authors: Robinson, BS Riccardi, KA Gong, YF Guo, Q Stock, DA Blair, WS Terry, BJ Deminie, CA Djang, F Colonno, RJ Lin, PF
Citation: Bs. Robinson et al., BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents, ANTIM AG CH, 44(8), 2000, pp. 2093-2099

Authors: Luo, GX Hamatake, RK Mathis, DM Racela, J Rigat, KL Lemm, J Colonno, RJ
Citation: Gx. Luo et al., De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus, J VIROLOGY, 74(2), 2000, pp. 851-863

Authors: Lin, PF Gonzalez, CJ Griffith, B Friedland, G Calvez, V Ferchal, F Schinazi, RF Shepp, DH Ashraf, AB Wainberg, MA Soriano, V Mellors, JW Colonno, RJ
Citation: Pf. Lin et al., Stavudine resistance: an update on susceptibility following prolonged therapy, ANTIVIR TH, 4(1), 1999, pp. 21-28

Authors: Genovesi, EV Lamb, L Medina, I Taylor, D Seifer, M Innaimo, S Colonno, RJ Standring, DN Clark, JM
Citation: Ev. Genovesi et al., Efficacy of the carbocyclic 2 '-deoxyguanosine nucleoside EMS-200475 in the woodchuck model of hepatitis B virus infection (vol 42, pg 3209, 1998), ANTIM AG CH, 43(3), 1999, pp. 726-726

Authors: Yamanaka, G Wilson, T Innaimo, S Bisacchi, GS Egli, P Rinehart, JK Zahler, R Colonno, RJ
Citation: G. Yamanaka et al., Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus, ANTIM AG CH, 43(1), 1999, pp. 190-193

Authors: Cianci, C Yu, KL Dischino, DD Harte, W Deshpande, M Luo, GX Colonno, RJ Meanwell, NA Krystal, M
Citation: C. Cianci et al., pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion, J VIROLOGY, 73(3), 1999, pp. 1785-1794

Authors: Seifer, M Hamatake, RK Colonno, RJ Standring, DN
Citation: M. Seifer et al., In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir, ANTIM AG CH, 42(12), 1998, pp. 3200-3208

Authors: Genovesi, EV Lamb, L Medina, I Taylor, D Seifer, M Innaimo, S Colonno, RJ Standring, DN Clark, JM
Citation: Ev. Genovesi et al., Efficacy of the carbocyclic 2 '-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection, ANTIM AG CH, 42(12), 1998, pp. 3209-3217
Risultati: 1-11 |